Sponsor or institution
Clinical trials and research at Najit Technologies, INC.
As of November 12, 2026, Find a Trial lists 4 NIH-funded research projects at this institution, with $3.8 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4NIH research projects
NIH-funded research (4)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
HydroVax-CHIKV: a first-in-human vaccine against chikungunya for adults and at-risk groups
A first-in-human phase I trial tests a new inactivated chikungunya vaccine to see if it is safe and prompts an immune response in adults.
-
HydroVax-CHIKV: an inactivated chikungunya vaccine for adults
A new inactivated chikungunya vaccine being given to healthy adults to check safety and immune response.
-
Testing a new vaccine for the Chikungunya virus
This study is testing a new vaccine called HydroVax-CHIKV to see how safe it is and how well it helps your body fight off the Chikungunya virus, which can make people very sick, especially during outbreaks, and it's looking for volunteers to help find the best dose for protection.
-
A new vaccine for yellow fever that is safe for everyone.
This study is testing a new yellow fever vaccine called HydroVax-YFV to see if it's safe and effective for people who can't get the usual vaccine, like infants, pregnant women, and older adults.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.